2Test

2025

1. Wolgast N, Amelunxen E, Fransecky L, Altrock P, Beder T, Ronnacker J, Peters F, Kim-Wanner SZ, Brüggemann M, Pott C, Katalinic A, Baldus CD, Baden D. Epidemiology and survival of patients with T-cell prolymphocytic leukemia.. Blood cancer journal 2025;15(1):206. doi:10.1038/s41408-025-01428-0

2020

1. Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hübner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program.. International journal of cancer 2020;147(3):709-718. doi:10.1002/ijc.32767

2016

1. Katalinic A. [Improved prognosis for symptom-free older women with mammography-detected breast cancer?].. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2016;192(2):130-132. doi:10.1007/s00066-015-0930-3

2012

1. Schnoor M, Waldmann A, Eberle A, Holleczek B, Katalinic A. Colorectal cancer incidence in Germany: stage-shift 6 years after implementation of a colonoscopy screening program.. Cancer epidemiology 2012;36(5):417-420. doi:10.1016/j.canep.2012.04.008
2. Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A. Systematic skin cancer screening in Northern Germany.. Journal of the American Academy of Dermatology 2012;66(2):201-211. doi:10.1016/j.jaad.2010.11.016

2007

1. Katalinic A, Bartel C, Raspe H, Schreer I. Beyond mammography screening: quality assurance in breast cancer diagnosis (The QuaMaDi Project).. British journal of cancer 2007;96(1):157-161. doi:10.1038/sj.bjc.6603506

2006

1. Stang A, Streller B, Katalinic A, Lehnert M, Eisinger B, Kaatsch P, Jöckel KH. Incidence of skin lymphoma in Germany.. Annals of epidemiology 2006;16(3):214-222. doi:10.1016/j.annepidem.2005.04.002